National Cancer Institute

FY 2014 Research Funding by Research Topic

Cancer Type Funded Amount
Agent Orange/Dioxin Related $701,445
Aging $63,983,878
Alcoholism Research $568,816
Arctic $1,141,360
Arthritis $1,365,410
Ataxia Telangiectasia $928,457
Autoimmune Diseases $7,269,931
Basic Behavioral and Social Science $70,786,746
Behavioral and Social Science $250,003,791
Biochemical Epidemiology $211,867,513
Bioengineering $159,524,844
Bone Marrow Transplantation $43,140,470
Cancer $4,932,807,990
Cancer Survivorship $179,888,055
Cervical Cancer Education $6,092,826
Chemoprevention $108,326,376
Chemotherapy $278,101,806
Childhood Cancers $203,716,485
Chronic Myeloproliferative Disorders $36,747,316
Contraception and Reproduction Research $1,682,200
Depression Research $11,606,228
Diabetes $10,703,005
Digestive Diseases $423,295,398
Down Syndrome $548,567
Gene Therapy $46,781,139
Gene Therapy Clinical Trials $8,140,400
Genetic Testing $45,984,671
Herpes - Genital $89,098
Herpes - Other $44,961,508
Inflammatory Bowel Disease $1,926,833
Interferon $4,284,886
Metastasis $362,567,754
Neurofibromatosis $5,825,776
Nuclear Magnetic Resonance Imaging (NMR) $86,827,034
Nursing Oncology $12,641,481
Organ Transplantation Research $51,470,461
Pesticides $1,024,973
Sleep Disorders $7,180,960
Smoking Behavior $69,795,644
Surgery $53,916,363
Taxol $18,673,073
Tuberous Sclerosis $1,863,806